Bristol-Myers Squibb Co (BMY) Receives Consensus Recommendation of "Hold" from Brokerages

Adjust Comment Print

Dalton Greiner Hartman Maher & Co bought 98,245 shares as the company's stock rose 6.65% with the market. The institutional investor held 90,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.74M, up from 45,000 at the end of the previous reported quarter. Pictet & Cie Europe Sa who had been investing in Visa Inc for a number of months, seems to be less bullish one the $281.19B market cap company. BMY stock is now showing negative return of -0.48% throughout last week and witnessed rising return of 8.04% in one month period. About 4.23 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 27, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Farr Miller & Washington Llc increased its stake in Bristol Myers Squibb (BMY) by 573.52% based on its latest 2017Q3 regulatory filing with the SEC. Financial Counselors Inc bought 15,730 shares as the company's stock declined 1.04% while stock markets rallied. The stock increased 0.47% or $0.9 during the last trading session, reaching $194.19. Bristol-Myers Squibb Company (BMY) finalized the Monday at price of $68.63 after traded 4229251 shares.

To: All persons or entities who purchased or otherwise acquired securities of Bristol-Myers Squibb Company ("Bristol-Myers") (NYSE:BMY) between January 27, 2015 and October 9, 2016. It has underperformed by 39.89% the S&P500.

Since September 6, 2017, it had 1 insider purchase, and 2 selling transactions for $646,385 activity. The rating was initiated by Societe Generale on Wednesday, April 6 with "Sell". Also, Director Theodore R. Samuels II acquired 4,000 shares of Bristol-Myers Squibb stock in a transaction that occurred on Friday, December 15th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company. Therefore 95% are positive. BMO Capital Markets set a $51.00 price objective on Bristol-Myers Squibb and gave the company a "sell" rating in a research report on Wednesday, February 14th. Citigroup set a $72.00 target price on Bristol-Myers Squibb and gave the stock a "buy" rating in a research note on Tuesday, December 5th. The company was maintained on Friday, September 15 by Jefferies. The average 12 month target price among brokers that have issued ratings on the stock in the previous year is $66.05. SunTrust Banks upgraded Bristol-Myers Squibb from a "hold" rating to a "buy" rating in a report on Monday, October 30th. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned "Hold" rating by Jefferies on Tuesday, June 14. The company was maintained on Monday, July 17 by Deutsche Bank. The firm has "Overweight" rating by Morgan Stanley given on Thursday, February 15. Granite Point Management Limited Partnership reported 0.4% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). The biopharmaceutical company reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.01. BMY's profit will be $1.42B for 19.72 P/E if the $0.87 EPS becomes a reality. Patriot Wealth Management Inc.'s holdings in Bristol-Myers Squibb were worth $4,743,000 as of its most recent SEC filing.

If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it. Its down 0.15, from 1.06 in 2017Q2. 137 funds opened positions while 460 raised stakes. Compton Cap Management Ri has invested 1.09% in Bristol-Myers Squibb Company (NYSE:BMY). Chevy Chase Tru owns 1.49 million shares. Bristol-Myers Squibb Co has a 52 week low of $51.56 and a 52 week high of $70.05. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned "Hold" rating by Berenberg on Thursday, August 11. During the same period in the previous year, the firm posted $0.63 earnings per share. analysts predict that Bristol-Myers Squibb Co will post 3.21 EPS for the current year. Citigroup maintained Bristol-Myers Squibb Company (NYSE:BMY) on Wednesday, October 25 with "Buy" rating. Puzo Michael J holds 11,200 shares. Riverhead Cap Management Ltd reported 10,187 shares. 8,788 were reported by First Bank Of Mount Dora Trust Investment Serv. Opus Investment Mngmt Incorporated owns 44,000 shares. Pekin Singer Strauss Asset Il, Illinois-based fund reported 37,246 shares.

Manufacturing sector growth eased in Feb: PMI
The index fell from 52.4 in January to 52.1 in February, indicating a modest improvement in operating conditions. The non-manufacturing purchasing managers' index came in at 54.4 this month, down from 55.3 in January.

Investors sentiment decreased to 0.8 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. 56 funds opened positions while 114 raised stakes. Sei Invests holds 0.13% or 581,758 shares in its portfolio. (NYSE:V). Excalibur Mgmt Corporation holds 10,959 shares. Stockholders of record on Friday, January 5th were given a $0.40 dividend. Following the completion of the transaction, the director now directly owns 22,000 shares in the company, valued at $1,370,600. It also increased its holding in Watsco Inc. 178,074 were accumulated by Scout Invests Inc. (NYSE:NKE). Gotham Asset Mgmt Ltd Liability invested in 0.07% or 88,966 shares. Mcmillion Mgmt reported 62,171 shares stake. Sit Inv Associates has 336,905 shares. New York-based Douglass Winthrop Ltd Com has invested 0.11% in Visa Inc. Gulf Bancorp (Uk) Ltd has 519,055 shares for 0.45% of their portfolio. (NYSE:V), 34 have Buy rating, 0 Sell and 8 Hold. Therefore 69% are positive. Brandywine Realty Trust had 32 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Underweight" rating given on Monday, August 24 by Piper Jaffray. Zacks Investment Research upgraded Bristol-Myers Squibb from a "hold" rating to a "buy" rating and set a $68.00 target price on the stock in a research note on Wednesday, November 1st. Mizuho downgraded the stock to "Neutral" rating in Friday, July 22 report.

When we see the company's Volatility, it now has a monthly volatility of 2.98% and weekly volatility of 2.26%. The stock of Visa Inc. On Friday, October 9 the stock rating was maintained by RBC Capital Markets with "Outperform". BMO Capital Markets has "Sell" rating and $49.0 target. First Bancorporation Of Omaha accumulated 16,364 shares or 0.06% of the stock. 1,712 Visa Inc. (NYSE:V) shares with value of $205,440 were sold by Biggar Lynne. On Monday, January 29 SPRUNK ERIC D sold $6.77M worth of NIKE, Inc.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. (NYSE:NKE) to report earnings on March, 20. The company's revenue was up 3.9% compared to the same quarter a year ago. This represents a $1.60 dividend on an annualized basis and a yield of 2.33%.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.